SOLEXAN Trademark

Trademark Overview

On Sunday, May 7, 2023, a trademark application was filed for SOLEXAN with the United States Patent and Trademark Office. The USPTO has given the SOLEXAN trademark a serial number of 97924284. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 9, 2025. This trademark is owned by Wintermute Biomedical Incorporated. The SOLEXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of blisters on the skin associated with shingles
solexan

General Information

Serial Number97924284
Word MarkSOLEXAN
Filing DateSunday, May 7, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of blisters on the skin associated with shingles

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWintermute Biomedical Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCorvallis, MT 59828
Party NameWintermute Biomedical Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorvallis, MT 59828

Trademark Events

Event DateEvent Description
Wednesday, May 10, 2023NEW APPLICATION ENTERED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Monday, June 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU EXTENSION 1 FILED
Monday, June 17, 2024SOU EXTENSION 1 GRANTED
Friday, June 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 9, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 20, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 9, 2025ABANDONMENT - NO USE STATEMENT FILED
Friday, June 21, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 21, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

solexan associated shingles skin blisters preparations treatment pharmaceutical